{"id":14026,"date":"2011-07-30T09:30:00","date_gmt":"2011-07-30T07:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/adoc-in-italia-i-farmaci-costano-troppo\/"},"modified":"2011-07-30T09:30:00","modified_gmt":"2011-07-30T07:30:00","slug":"adoc-in-italia-i-farmaci-costano-troppo","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/adoc-in-italia-i-farmaci-costano-troppo\/","title":{"rendered":"Adoc: "Drugs cost too much in Italy""},"content":{"rendered":"

Rome<\/em> \u2013 According to the prosecution of the Public Prosecutor of Florence, the multinational Bristol Myers Squibb Italia, together with the Menarini group, would have significantly inflated the selling prices of marketed drugs<\/strong>, obtaining an undue reimbursement of over one billion euros from the National Health Service. For Adoc, the scam has also enormously damaged consumers.<\/font><\/p>\n

"If the scam were confirmed it would be a very serious fact, it would mean that consumers would have suffered damages for millions of euros - declares Carlo Pileri, President of Adoc - for this reason we do not rule out a class action for the compensation of the economic damages suffered by thousands of consumers. For years we have argued that drugs cost too much, at least 30% more than in the rest of Europe.<\/font><\/p>\n

For this reason we ask for a meeting with the Minister of Health to clarify what we intend to do in the future, given that we pay for expensive drugs twice, the first with direct payment and the second with the payment of co-payments if it is paid by the State. In fact, being too expensive, the health system cannot bear the costs and forces us to pay co-payments. An operation, that of co-payments, which would not be necessary if the drugs cost like in the rest of Europe ".<\/font> NEWSFOOD.com editorial staff \u2013 29\/07\/2011<\/span><\/em><\/p>\n

\"\"<\/p>","protected":false},"excerpt":{"rendered":"

Roma – Secondo l’accusa della Procura della Repubblica di Firenze la multinazionale Bristol Myers Squibb Italia, assieme al gruppo Menarini, avrebbe gonfiato notevolmente i prezzi di vendita dei farmaci commercializzati, ottenendo un indebito rimborso di oltre un miliardo di euro dal Servizio Sanitario Nazionale. Per Adoc la truffa ha danneggiato enormemente anche i consumatori. "Se …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14026","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14026","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14026"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14026\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14026"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14026"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}